TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
about
Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 ActivationTLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation.A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach.Modulators of microglial activation and polarization after intracerebral haemorrhage.Particulate β-glucans synergistically activate TLR4 and Dectin-1 in human dendritic cells.Toll-like receptors and their role in persistent pain.Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands.Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling.Innately activated TLR4 signal in the nucleus accumbens is sustained by CRF amplification loop and regulates impulsivity.Contributions and Future Directions for Structural Biology in the Study of Allergens.The GABAA Receptor α2 Subunit Activates a Neuronal TLR4 Signal in the Ventral Tegmental Area that Regulates Alcohol and Nicotine Abuse.Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics.Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design.
P2860
Q35981265-A9492D3E-5261-4DDC-91D3-22CB48663200Q36162709-1E17CF29-B42A-46B6-AD63-2E73DD38627BQ37349893-D8E0CFE8-32F9-4335-8BFF-5BADFC8CA8B4Q37508658-5DCF00A8-AFB6-46B3-B615-99F04803AB1AQ39317715-F86C645C-72C0-4026-8005-2B7781666353Q39643927-9F183FF4-CC6F-4E90-83E0-6C767EE637C3Q43075865-044015C7-57CB-448C-ADFE-4E30174CC14FQ46091295-D9427936-502F-4AF3-B1ED-E39CDCCDAB0EQ46329132-58842DD4-0998-44EA-9FDE-931B9DE59E71Q47147061-2C1A4B41-440B-4B4E-94EF-1AB92463F933Q47577664-FC3295B1-14DD-4A9E-B8B7-F9EE3DF662B4Q47676049-5677BC73-D12A-4A7A-B2D0-DA248D690397Q53402920-348484CA-F0AE-44E6-A2CD-F3A5C87EB649Q54967965-A36004B9-F193-4FF9-A648-712F6D4722E8Q55196176-DB520BCE-9FF9-4EAB-8172-712FA10C5F5B
P2860
TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
@ast
TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
@en
type
label
TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
@ast
TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
@en
prefLabel
TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
@ast
TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
@en
P2093
P2860
P356
P1476
TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
@en
P2093
Brian T Jones
Dale L Boger
Eva Marie Y Moresco
Hong Zhang
Jin Huk Choi
Kuan-wen Wang
Landon R Whitby
P2860
P304
P356
10.1073/PNAS.1525639113
P407
P577
2016-02-01T00:00:00Z